Strides Pharma Science Limited has informed the Exchange that Board of Directors at its meeting held on May 18, 2026, recommended Final Dividend of Rs. 5 per equity share.
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Strides Pharma Science Limited's Board of Directors, in its meeting on May 18, 2026, recommended a final dividend of Rs. 5 per equity share (face value Rs. 10 each) at 50% payout for FY2026. The company also reported audited consolidated results with total income of Rs. 50,094 million for FY2026, up from Rs. 46,241 million in FY2025. Profit after tax from continuing operations stood at Rs. 5,745 million, a significant increase from Rs. 4,094 million in the previous year. The dividend is subject to shareholders' approval at the ensuing AGM, with payment due within 30 days of approval. Record date for determining eligible shareholders will be intimated separately.
The 50% dividend payout on a per-share basis reflects healthy profitability growth with PAT up 40% YoY. The dividend signals management confidence in sustained cash generation, though the absolute quantum (Rs. 5 per share) appears modest relative to the Rs. 60.34 EPS from continuing operations.